Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

Ovarian cancer is the deadliest of all gynecologic cancers, expected to kill about 15,000 women in 2008, according to the Ovarian Cancer National Alliance. Risk factors remain a mystery; however, researchers believe a woman is at increased risk if she has a family history of cancer, personal history of cancer, is older than 55, has never been pregnant, and has used menopausal hormone therapy.

To further complicate matters, ovarian cancer is hard to diagnose in its early stage. Only about 20 percent of ovarian cancer is found at the early stage. When found early, the survival rate is 95 percent over five years. Approximately 75 percent of ovarian cancer cases are diagnosed at an advanced stage after the cancer has spread beyond the ovary.

But a new method devised by researchers at the Fred Hutchinson Cancer Research Center in Seattle, Wash., has been found to increase the diagnosis of the disease by one third, according to FoodConsumer.org. The process used both a questionnaire on symptoms and blood tests. Using the questionnaire alone led to the discovery of early stage ovarian cancer in 60 percent of the cases. The blood test alone reported to same percentage of results. However, both the questionnaire and the blood test combined resulted in an early stage diagnosis in 80 percent of the cases.

Symptoms include bloating, pelvic and abdominal pain, difficulty eating or feeling full quickly, and urinary urgency or frequency. Additional symptoms may include fatigue, indigestion, back pain, pain with intercourse, constipation and menstrual irregularities. Blood tests to diagnose ovarian cancer include the CA-125. Other diagnostic tests include physical exam, pelvic exam, ultrasound and biopsy.

This entry was posted on Monday, October 27th, 2008 at 4:33 pm and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.